epigallocatechin gallate

insulin ; Homo sapiens







37 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35066640 Differential impact of cold and hot tea extracts on tyrosine phosphatases regulating insulin receptor activity: a focus on PTP1B and LMW-PTP. 2022 Jun 2
2 35124182 Enhanced alleviation of insulin resistance via the IRS-1/Akt/FOXO1 pathway by combining quercetin and EGCG and involving miR-27a-3p and miR-96-5p. 2022 Mar 3
3 34572974 Differential Effects of Polyphenols on Insulin Proteolysis by the Insulin-Degrading Enzyme. 2021 Aug 25 1
4 32499589 Amyloid Aggregation of Insulin: An Interaction Study of Green Tea Constituents. 2020 Jun 4 1
5 30926986 Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer. 2019 Apr 1 1
6 31091209 Decrement in Cellular Iron and Reactive Oxygen Species, and Improvement of Insulin Secretion in a Pancreatic Cell Line Using Green Tea Extract. 2019 May/Jun 4
7 31264419 Monitoring Insulin-Aggregated Structures in the Presence of Epigallocatechin-3-gallate and Melatonin by Molecular Dynamics Simulations. 2019 Jul 22 6
8 31835741 The Environment Is a Key Factor in Determining the Anti-Amyloid Efficacy of EGCG. 2019 Dec 11 1
9 29423494 EGCG evokes Nrf2 nuclear translocation and dampens PTP1B expression to ameliorate metabolic misalignment under insulin resistance condition. 2018 Mar 1 3
10 29727655 Human insulin fibrillogenesis in the presence of epigallocatechin gallate and melatonin: Structural insights from a biophysical approach. 2018 Aug 3
11 29868672 EGCG stimulates the recruitment of brite adipocytes, suppresses adipogenesis and counteracts TNF-α-triggered insulin resistance in adipocytes. 2018 Jun 20 2
12 29940201 Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity. 2018 Aug 1
13 28137482 Epigallocatechin-3-gallate (EGCG) activates AMPK through the inhibition of glutamate dehydrogenase in muscle and pancreatic ß-cells: A potential beneficial effect in the pre-diabetic state? 2017 Jul 4
14 28266082 Dietary epigallocatechin 3-gallate supplement improves maternal and neonatal treatment outcome of gestational diabetes mellitus: a double-blind randomised controlled trial. 2017 Dec 2
15 28393248 Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes. 2017 Jun 4
16 28739640 EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS. 2017 Nov 3
17 28869341 (-)-Epigallocatechin-3-gallate Ameliorates Insulin Resistance and Mitochondrial Dysfunction in HepG2 Cells: Involvement of Bmal1. 2017 Dec 7
18 29362600 Palmitate-induced insulin resistance is attenuated by Pioglitazone and EGCG through reducing the gluconeogenic key enzymes expression in HepG2 cells. 2017 Oct-Dec 4
19 25312214 Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate. 2015 3
20 25732404 Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced Toll-like receptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3-L1 adipocytes. 2015 Mar 18 3
21 25757931 Structure-dependent inhibitory effects of green tea catechins on insulin secretion from pancreatic β-cells. 2015 1
22 24572069 Modeling of chemical inhibition from amyloid protein aggregation kinetics. 2014 Feb 27 1
23 24066304 Green tea polyphenol epigallocatechin-3-gallate enhance glycogen synthesis and inhibit lipogenesis in hepatocytes. 2013 2
24 22333569 Formation of low-dimensional crystalline nucleus region during insulin amyloidogenesis process. 2012 Mar 9 1
25 22342466 Chitosan-based luminescent/magnetic hybrid nanogels for insulin delivery, cell imaging, and antidiabetic research of dietary supplements. 2012 May 10 2
26 22537475 Investigation into the mechanism of (-)-epigallocatechin-3-gallate-induced precipitation of insulin. 2012 Jun 1 10
27 21193040 Weight control and prevention of metabolic syndrome by green tea. 2011 Aug 1
28 21649457 Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. 2011 Jun 1
29 20596890 (-) Epigallocatechin gallate suppresses the differentiation of 3T3-L1 preadipocytes through transcription factors FoxO1 and SREBP1c. 2010 Jul 1
30 18710606 Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. 2009 Mar 1
31 19176763 Green tea (-)-epigallocatechin gallate inhibits insulin stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor pathway. 2009 Jul 9
32 18496818 Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. 2008 Aug 7
33 18537694 Mechanisms underlying beneficial health effects of tea catechins to improve insulin resistance and endothelial dysfunction. 2008 Jun 1
34 16950602 Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. 2007 Feb 6
35 17227956 EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. 2007 May 5
36 16470636 Anti-obesity effects of green tea: from bedside to bench. 2006 Feb 2
37 12118006 Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. 2002 Sep 20 5